Takeda Pharmaceuticals International GmbH has expanded its commercial platform, establishing a subsidiary in Israel. The company has also opened offices in Algeria, Ecuador, Peru, Singapore and Vietnam this year as part of its growth platform.
 
Takeda Israel LTD will be headquartered in Tel Aviv and will be responsible for the sales and marketing of selected products from Takeda’s portfolio, with an initial focus on oncology. Takeda Israel will also seek local partners to launch additional medicines from its current portfolio.
 
Arie Kramer has been appointed country manager for Israel. He joins the company from AbbVie Biopharma, where he headed finance and strategic commercial planning. Previously served as general manager, chief financial officer and operations manager at Novartis Consumer Health in Israel.
 
“There is a growing demand for specialty treatments in Israel,” said Arie Kramer, Country manager Takeda Israel. “The establishment of our subsidiary demonstrates our commitment to bringing innovative new medicines to patients and will enable us to address some of the country’s current unmet healthcare needs.”